Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells.

Saathoff JG, Inman AO, Xia XR, Riviere JE, Monteiro-Riviere NA.

Toxicol In Vitro. 2011 Dec;25(8):2105-12. doi: 10.1016/j.tiv.2011.09.013. Epub 2011 Sep 22.

2.

Toxicity studies of fullerenes and derivatives.

Kolosnjaj J, Szwarc H, Moussa F.

Adv Exp Med Biol. 2007;620:168-80. Review.

PMID:
18217343
3.

The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.

Johnston HJ, Hutchison GR, Christensen FM, Aschberger K, Stone V.

Toxicol Sci. 2010 Apr;114(2):162-82. doi: 10.1093/toxsci/kfp265. Epub 2009 Nov 9. Review.

PMID:
19901017
4.

Fullerenol nanoparticles: toxicity and antioxidant activity.

Injac R, Prijatelj M, Strukelj B.

Methods Mol Biol. 2013;1028:75-100. doi: 10.1007/978-1-62703-475-3_5. Review.

PMID:
23740114
5.

Structure and dynamics in self-organized C60 fullerenes.

Patnaik A.

J Nanosci Nanotechnol. 2007 Apr-May;7(4-5):1111-50. Review.

PMID:
17450883
6.

[Biological effect of fullerene (C60) to lung by inhalation or instillation].

Ogami A, Morimoto Y, Myojo T, Oyabu T.

J UOEH. 2012 Mar 1;34(1):65-75. Review. Japanese.

PMID:
22428460
7.

Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).

Markovic Z, Trajkovic V.

Biomaterials. 2008 Sep;29(26):3561-73. doi: 10.1016/j.biomaterials.2008.05.005. Epub 2008 Jun 4. Review.

PMID:
18534675
8.

Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature.

Aschberger K, Johnston HJ, Stone V, Aitken RJ, Tran CL, Hankin SM, Peters SA, Christensen FM.

Regul Toxicol Pharmacol. 2010 Dec;58(3):455-73. doi: 10.1016/j.yrtph.2010.08.017. Epub 2010 Aug 26. Review.

PMID:
20800639
9.

Fullerenes as Anti-Aging Antioxidants.

Galvan YP, Alperovich I, Zolotukhin P, Prazdnova E, Mazanko M, Belanova A, Chistyakov V.

Curr Aging Sci. 2017;10(1):56-67. Review.

PMID:
27659261
10.

Medicinal applications of fullerenes.

Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, Bonn GK.

Int J Nanomedicine. 2007;2(4):639-49. Review.

11.

The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Liu Q, Cui Q, Li XJ, Jin L.

Connect Tissue Res. 2014 Apr;55(2):71-9. doi: 10.3109/03008207.2013.877894. Epub 2014 Jan 24. Review.

12.

[Fullerenols in therapy and diagnosis of cancer].

Lichota A, Krokosz A.

Med Pr. 2016 Dec 22;67(6):817-831. doi: 10.13075/mp.5893.00466. Epub 2016 Nov 22. Review. Polish.

13.

Fullerenols as a new therapeutic approach in nanomedicine.

Grebowski J, Kazmierska P, Krokosz A.

Biomed Res Int. 2013;2013:751913. doi: 10.1155/2013/751913. Epub 2013 Oct 7. Review.

Supplemental Content

Support Center